This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
4cyq
From Proteopedia
(Difference between revisions)
| (4 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
| + | |||
==Leishmania major N-myristoyltransferase in complex with a hybrid inhibitor (compound 45).== | ==Leishmania major N-myristoyltransferase in complex with a hybrid inhibitor (compound 45).== | ||
| - | <StructureSection load='4cyq' size='340' side='right' caption='[[4cyq]], [[Resolution|resolution]] 1.65Å' scene=''> | + | <StructureSection load='4cyq' size='340' side='right'caption='[[4cyq]], [[Resolution|resolution]] 1.65Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[4cyq]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4CYQ OCA]. For a <b>guided tour on the structure components</b> use [ | + | <table><tr><td colspan='2'>[[4cyq]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Leishmania_major Leishmania major]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4CYQ OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4CYQ FirstGlance]. <br> |
| - | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene>, <scene name='pdbligand=MYA:TETRADECANOYL-COA'>MYA</scene>, <scene name='pdbligand=YAU:N-{2-CHLORO-5-[(3S,4R)-1-[(3R)-4-(4-CHLOROPHENYL)-3-HYDROXYBUTANOYL]-4-(HYDROXYMETHYL)PYRROLIDIN-3-YL]PHENYL}-2-(4-FLUOROPHENYL)ACETAMIDE'>YAU</scene | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.65Å</td></tr> |
| - | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene>, <scene name='pdbligand=MYA:TETRADECANOYL-COA'>MYA</scene>, <scene name='pdbligand=YAU:N-{2-CHLORO-5-[(3S,4R)-1-[(3R)-4-(4-CHLOROPHENYL)-3-HYDROXYBUTANOYL]-4-(HYDROXYMETHYL)PYRROLIDIN-3-YL]PHENYL}-2-(4-FLUOROPHENYL)ACETAMIDE'>YAU</scene></td></tr> | |
| - | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4cyq FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4cyq OCA], [https://pdbe.org/4cyq PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4cyq RCSB], [https://www.ebi.ac.uk/pdbsum/4cyq PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4cyq ProSAT]</span></td></tr> | |
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | |
</table> | </table> | ||
| + | == Function == | ||
| + | [https://www.uniprot.org/uniprot/Q4Q5S8_LEIMA Q4Q5S8_LEIMA] Adds a myristoyl group to the N-terminal glycine residue of certain cellular proteins (By similarity). | ||
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
| Line 16: | Line 18: | ||
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
</div> | </div> | ||
| + | <div class="pdbe-citations 4cyq" style="background-color:#fffaf0;"></div> | ||
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
| - | [[Category: | + | [[Category: Large Structures]] |
| - | [[Category: Bell | + | [[Category: Leishmania major]] |
| - | [[Category: Brannigan | + | [[Category: Bell AS]] |
| - | [[Category: Goncalves | + | [[Category: Brannigan JA]] |
| - | [[Category: Hutton | + | [[Category: Goncalves V]] |
| - | [[Category: Leatherbarrow | + | [[Category: Hutton JA]] |
| - | [[Category: Paape | + | [[Category: Leatherbarrow RJ]] |
| - | [[Category: Roberts | + | [[Category: Paape D]] |
| - | [[Category: Smith | + | [[Category: Roberts SM]] |
| - | [[Category: Tate | + | [[Category: Smith DF]] |
| - | [[Category: Waugh | + | [[Category: Tate EW]] |
| - | [[Category: Wilkinson | + | [[Category: Waugh T]] |
| - | + | [[Category: Wilkinson AJ]] | |
| - | + | ||
| - | + | ||
| - | + | ||
Current revision
Leishmania major N-myristoyltransferase in complex with a hybrid inhibitor (compound 45).
| |||||||||||
Categories: Large Structures | Leishmania major | Bell AS | Brannigan JA | Goncalves V | Hutton JA | Leatherbarrow RJ | Paape D | Roberts SM | Smith DF | Tate EW | Waugh T | Wilkinson AJ
